Interpharm Holdings, Inc. (IPAH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 9, 2025
Interpharm Holdings Revenue
Interpharm Holdings had revenue of $16.21M in the quarter ending December 31, 2007, a decrease of -7.24%. This brings the company's revenue in the last twelve months to $69.21M, down -5.06% year-over-year. In the fiscal year ending June 30, 2007, Interpharm Holdings had annual revenue of $75.59M with 19.31% growth.
Revenue (ttm)
69.21M
Revenue Growth
-5.06%
P/S Ratio
n/a
Revenue / Employee
103.30K
Employees
670
Market Cap
67.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2007 | 75.59M | 12.23M | 19.31% |
| Jun 30, 2006 | 63.36M | 23.44M | 58.74% |
| Jun 30, 2005 | 39.91M | -1.19M | -2.89% |
| Jun 30, 2004 | 41.10M | 13.58M | 49.33% |
| Jun 30, 2003 | 27.52M | 3.21M | 13.20% |
| Dec 31, 2002 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2001 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2000 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inyx, Inc. | 85.04M |
| Chalice Brands | 25.96M |
| Goodbody Health | 18.35M |
| Isodiol International | 12.18M |
| MJardin Group | 4.81M |
| CEN Biotech | 1.03M |
| Allied | 104.81K |